Quiet Therapeutics Overview
- Founded
- 2010
- Status
- Out of Business
- Employees
- 4
- Latest Deal Type
- Liquidation
Quiet Therapeutics General Information
Description
Developer of cancer drugs designed to specifically target tumor cells. The company's drugs utilize its proprietary GAGomer technology that target the specific cancer cells, that leads to the death of the cancer cells, enabling healthcare providers to cure their patients and improve their lives.
Contact Information
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Primary Office
- 18 Einstein Street, 5th floor
- POB: 4053
- Ness Ziona 74140
- Israel
+972 000-000-0000
Quiet Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Bankruptcy: Liquidation | 01-Jan-2017 | 000.00 | Completed | Out of Business | ||
| 3. Early Stage VC (Series A) | 01-Apr-2015 | 0000 | 000.00 | Completed | Startup | |
| 2. Grant | 01-Nov-2013 | $2.86M | $5.5M | Completed | Startup | |
| 1. Early Stage VC | 15-Jan-2013 | $5.5M | $5.5M | Completed | Startup |
Quiet Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cancer drugs designed to specifically target tumor cells. The company's drugs utilize its proprietary GAGom
Drug Delivery
Ness Ziona, Israel
4
As of 2014
000.00
000000000000
000.00
0000000
ed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nost
0000 000000000
Muttenz, Switzerland
00
As of 0000
000.00
000000 0
00000000
illum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa
0000 000000000
Uppsala, Sweden
00
As of 0000
0000000000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialQuiet Therapeutics Competitors (5)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| TOLREMO therapeutics | Venture Capital-Backed | Muttenz, Switzerland | 00 | 000.00 | 000000 0 | |
| 00000000 000000000 | Venture Capital-Backed | Uppsala, Sweden | 00 | 0000000000 | ||
| 000000000 | Formerly PE-Backed | Planegg, Germany | 000 | 00000 | 000000000 | 00000 |
| 0000000 | Venture Capital-Backed | Newhouse, United Kingdom | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000 0000000000 | Formerly VC-backed | Brisbane, CA | 000 | 000.00 | 00000000 | 000.00 |
Quiet Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial